These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7075118)

  • 1. Effects of probenecid on ketoprofen kinetics.
    Upton RA; Williams RL; Buskin JN; Jones RM
    Clin Pharmacol Ther; 1982 Jun; 31(6):705-12. PubMed ID: 7075118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.
    Macdonald JI; Wallace SM; Herman RJ; Verbeeck RK
    Eur J Clin Pharmacol; 1995; 47(6):519-23. PubMed ID: 7768255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ketoprofen in patients with chronic renal failure.
    Stafanger G; Larsen HW; Hansen H; Sørensen
    Scand J Rheumatol; 1981; 10(3):189-92. PubMed ID: 7291952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoprofen-aspirin interactions.
    Williams RL; Upton RA; Buskin JN; Jones RM
    Clin Pharmacol Ther; 1981 Aug; 30(2):226-31. PubMed ID: 7249506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.
    Verbeeck RK; Wallace SM; Loewen GR
    Br J Clin Pharmacol; 1984 Jun; 17(6):783-4. PubMed ID: 6743473
    [No Abstract]   [Full Text] [Related]  

  • 6. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.
    Abas A; Meffin PJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):637-41. PubMed ID: 3806417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoprofen-probenecid interaction in the rat: a probenecid concentration-dependent stereoselective process.
    Palylyk EL; Jamali F
    J Pharm Sci; 1993 Mar; 82(3):296-300. PubMed ID: 8450425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of ketoprofen enantiomers and probenecid in plasma and urine by high-performance liquid chromatography.
    Palylyk EL; Jamali F
    J Chromatogr; 1991 Jul; 568(1):187-96. PubMed ID: 1770096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay.
    Upton RA; Williams RL; Guentert TW; Buskin JN; Riegelman S
    Eur J Clin Pharmacol; 1981; 20(2):127-33. PubMed ID: 7262174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ketoprofen in the elderly.
    Advenier C; Roux A; Gobert C; Massias P; Varoquaux O; Flouvat B
    Br J Clin Pharmacol; 1983 Jul; 16(1):65-70. PubMed ID: 6882624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.
    Ishizaki T; Sasaki T; Suganuma T; Horai Y; Chiba K; Watanabe M; Asuke W; Hoshi H
    Eur J Clin Pharmacol; 1980 Nov; 18(5):407-14. PubMed ID: 7439263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian changes in the pharmacokinetics of oral ketoprofen.
    Ollagnier M; Decousus H; Cherrah Y; Levi F; Mechkouri M; Queneau P; Reinberg A
    Clin Pharmacokinet; 1987 May; 12(5):367-78. PubMed ID: 3608343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability study on a new slow-release formulation of ketoprofen.
    Caruso I; Frigerio E; Fumagalli M; Liverta C; Moro L; Tamassia V
    J Int Med Res; 1982; 10(4):229-33. PubMed ID: 7117681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ketoprofen enantiomers in cholecystectomy patients: influence of probenecid.
    Foster RT; Jamali F; Russell AS
    Eur J Clin Pharmacol; 1989; 37(6):589-94. PubMed ID: 2612555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.
    Upton RA; Buskin JN; Williams RL; Holford NH; Riegelman S
    J Pharm Sci; 1980 Nov; 69(11):1254-7. PubMed ID: 7452451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the absorption of ketoprofen topically administered in man: comparison between tissue and plasma levels.
    Ballerini R; Casini A; Chinol M; Mannucci C; Giaccai L; Salvi M
    Int J Clin Pharmacol Res; 1986; 6(1):69-72. PubMed ID: 3957503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion.
    Debruyne D; Hurault de Ligny B; Ryckelynck JP; Albessard F; Moulin M
    Clin Pharmacokinet; 1987 Mar; 12(3):214-21. PubMed ID: 3581635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of meal size and composition on the bioavailability of ketoprofen (Oruvail).
    Nievel JG; Havard CW; Mitchell P; Gudgeon A; Kaye CM
    Xenobiotica; 1987 Apr; 17(4):487-92. PubMed ID: 3604255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
    Houghton GW; Dennis MJ; Templeton R; Calvert RM; Cresswell DG
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):131-3. PubMed ID: 6715081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.